First clinical trial for vaccine targeting Alzheimer’s in people with Down’s syndrome

by Nicholas Jackson | drugtargetreview.com

Plans for the world’s first clinical trial for a vaccine targeting Alzheimer’s disease-like characteristics in those with Down’s syndrome have been announced. The study will test AC Immune’s vaccine ACI-24 and is being conducted in collaboration with the University of California, San Diego (UC San Diego) Down’s Syndrome Research and Treatment Center. Funding is provided by a significant grant from the US National Institutes of Health (NIH) and an additional grant from the LuMind Research Down’s Syndrome Foundation. This is the first public/private collaboration for a clinical trial in the field of Down’s syndrome.

http://www.drugtargetreview.com/8541/content-type/industry-news/vaccine-targeting-alzheimers-in-people-with-down-syndrome/#.Vo6bUU-ng2Y.facebook